Immunotherapy
Geoffrey M. Lowman, PhD @thermofisher #Immunotherapy #Oncology #TCRSequencing #Cancer #Research Haplotype Analysis of the TCRB Locus by Long-amplicon TCRB Repertoire Sequencing
Tito R. Mendoza, PhD, MS, MEd @MDAndersonNews #Immunotherapy #Cancer #Research Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
Daniel Catenacci, MD @DocCatenacci @UChicagoMed #immunotherapy #cancer #research Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE
Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...
Jennifer Baker Flechtner, Ph.D. @GenoceaBio #AACR #immunotherapy Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology
Jacob J. Adashek, DO @MoffittNews @ASCO20 Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.
Jared Gollob @JaredGollob @KymeraTx #AACR20 What's the Advantage of IRAK4 Combined into One Molecule
Jared Gollob @JaredGollob @KymeraTx #AACR20 IRAKIMiD Degrader Program and Present Preclinical Data Demonstrating Potent Immunomodulatory and Antitumor Activity for its Novel STAT3 Degraders
Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor cells - In Closing - John Williams Ph.D. - City of Hope @cityofhope #cartcells #CAR-T
Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor cells - Will this affect clinicians - John Williams Ph.D. - City of Hope @cityofhope #cartcells #...
